Virological, immune and host genetics markers in the control of HIV infection

被引:0
作者
Mothe, Beatriz [1 ,2 ]
Ibarrondo, Javier [1 ,2 ]
Llano, Anuska [1 ,2 ]
Brander, Christian [1 ,2 ,3 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona 08916, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] ICREA, Barcelona, Spain
关键词
HIV-1; long-term non-progressors (LTNP); Elite Controllers (EC); Highly exposed persistently seronegatives (HEPS); CCR5; CTL; Innate immunity; HIV control; immune correlates; HLA allele frequency; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC-T-LYMPHOCYTE; LONG-TERM SURVIVORS; CLASS-I MOLECULES; CELL RESPONSES; DISEASE PROGRESSION; HLA-B; PROMOTER POLYMORPHISM; VIRAL LOAD; CHEMOKINE RECEPTORS;
D O I
10.1155/2009/360362
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
HIV infection, if left untreated, leads in most cases to the development of wide immune deterioration, opportunistic infections and eventually AIDS and death. The identification of individuals who despite persisting infection show no or few signs of HIV disease progression has spurred hopes that an effective HIV vaccine could be attainable. The design of such a vaccine will greatly depend on the precise definition of disease markers, host genetic and immune characteristics that mediate relative in vivo control of this virus. Accordingly, a number of viral factors and host genetic characteristics have been shown to play a crucial role in the control of HIV disease by delaying progression to AIDS or even preventing infection. There is also an improved understanding of humoral and cellular immune responses in terms of specificity, functional repertoire, longevity and tissue distribution and their ability to contain HIV replication. However, the definition of good immune correlates unequivocally and causally associated with protection or disease progression remains elusive. Here we review work on viral factors, host genetic markers and immunological determinants that have been identified in individuals with superior control of HIV infection or in subjects who remain uninfected despite frequent exposure to the viral pathogen.
引用
收藏
页码:105 / 120
页数:16
相关论文
共 148 条
[1]   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection [J].
Alexander, L ;
Weiskopf, E ;
Greenough, TC ;
Gaddis, NC ;
Auerbach, MR ;
Malim, MH ;
O'Brien, SJ ;
Walker, BD ;
Sullivan, JL ;
Desrosiers, RC .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4361-4376
[2]   Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution [J].
Allen, TM ;
Altfeld, M ;
Geer, SC ;
Kalife, ET ;
Moore, C ;
O'Sullivan, KM ;
DeSouza, I ;
Feeney, ME ;
Eldridge, RL ;
Maier, EL ;
Kaufmann, DE ;
Lahaie, MP ;
Reyor, L ;
Tanzi, G ;
Johnston, MN ;
Brander, C ;
Draenert, R ;
Rockstroh, JK ;
Jessen, H ;
Rosenberg, ES ;
Mallal, SA ;
Walker, BD .
JOURNAL OF VIROLOGY, 2005, 79 (21) :13239-13249
[3]   Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection [J].
Allen, TM ;
Altfeld, M ;
Yu, XG ;
O'Sullivan, KM ;
Lichterfeld, M ;
Le Gall, S ;
John, M ;
Mothe, BR ;
Lee, PK ;
Kalife, ET ;
Cohen, DE ;
Freedberg, KA ;
Strick, DA ;
Johnston, MN ;
Sette, A ;
Rosenberg, ES ;
Mallal, SA ;
Goulder, PJR ;
Brander, C ;
Walker, BD .
JOURNAL OF VIROLOGY, 2004, 78 (13) :7069-7078
[4]   Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes [J].
Alter, Galit ;
Martin, Maureen P. ;
Teigen, Nickolas ;
Carr, William H. ;
Suscovich, Todd J. ;
Schneidewind, Arne ;
Streeck, Hendrik ;
Waring, Michael ;
Meier, Angela ;
Brander, Christian ;
Lifson, Jeffrey D. ;
Allen, Todd M. ;
Carrington, Mary ;
Altfeld, Marcus .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (12) :3027-3036
[5]   HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8+ T cell response against HIV-1 [J].
Altfeld, Marcus ;
Kalife, Elizabeth T. ;
Qi, Ying ;
Streeck, Hendrik ;
Lichterfeld, Mathias ;
Johnston, Mary N. ;
Burgett, Nicole ;
Swartz, Martha E. ;
Yang, Amy ;
Alter, Galit ;
Yu, Xu G. ;
Meier, Angela ;
Rockstroh, Juergen K. ;
Allen, Todd M. ;
Jessen, Heiko ;
Rosenberg, Eric S. ;
Carrington, Mary ;
Walker, Bruce D. .
PLOS MEDICINE, 2006, 3 (10) :1851-1864
[6]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[7]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[8]   A new classification for HIV-1 [J].
Berger, EA ;
Doms, RW ;
Fenyö, EM ;
Korber, BTM ;
Littman, DR ;
Moore, JP ;
Sattentau, QJ ;
Schuitemaker, H ;
Sodroski, J ;
Weiss, RA .
NATURE, 1998, 391 (6664) :240-240
[9]   HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].
Betts, Michael R. ;
Nason, Martha C. ;
West, Sadie M. ;
De Rosa, Stephen C. ;
Migueles, Stephen A. ;
Abraham, Jonathan ;
Lederman, Michael M. ;
Benito, Jose M. ;
Goepfert, Paul A. ;
Connors, Mark ;
Roederer, Mario ;
Koup, Richard A. .
BLOOD, 2006, 107 (12) :4781-4789
[10]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991